Clinical performance of the Abbott Alinity anti-HBc immunoassay and its association with FIB-4 score in risk stratification of liver fibrosis.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Diagnostic microbiology and infectious disease

• Publication date

  2025-07-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.diagmicrobio.2025.117018PMID 40714696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.

  2025cited by this paper
• A need for confirmatory testing of isolated HBcAb-positive results in screening programs

  2024cited by this paper
• Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen

  2024cited by this paper
• Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?

  2024cited by this paper
• Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis

  2024cited by this paper
• Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control.

  2024cited by this paper
• Global burden of hepatitis B virus: current status, missed opportunities and a call for action

  2023cited by this paper
• Hepatitis B Virus-Associated Hepatocellular Carcinoma

  2022cited by this paper
• Prevalence of Cirrhosis/Advanced Fibrosis Among HBsAg-Negative and HBcAb-Positive US Adults: A Nationwide Population-Based Study

  2022cited by this paper
• The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts

  2022cited by this paper
• Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease

  2022cited by this paper
• Insights on 21 Years of HBV Surveillance in Blood Donors in France

  2022cited by this paper
• How effective are APRI, FIB-4, FIB-5 scores in predicting liver fibrosis in chronic hepatitis B patients?

  2022cited by this paper
• Correlation of serological and molecular markers in the screening for hepatitis B virus in blood bank in northern Brazil

  2022cited by this paper
• High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis

  2021cited by this paper
• Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting

  2021cited by this paper
• Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

  2020cited by this paper
• Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen‐Seronegative Patients

  2019cited by this paper
• Assessment of the impact of the extension of vaccination mandates on vaccine coverage after 1 year, France, 2019

  2019cited by this paper
• Positive HBs antigen in the absence of hepatitis B virus infection.

  2019cited by this paper
• Diagnostic value of FIB-4 for liver fibrosis in patients with hepatitis B: a meta-analysis of diagnostic test

  2017cited by this paper
• One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling

  2017cited by this paper
• Significance of anti-HBc alone serological status in clinical practice.

  2017cited by this paper
• Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

  2016cited by this paper
• Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.

  2015cited by this paper
• How do we handle the anti‐HBc positive patient? (in highly endemic settings)

  2015cited by this paper
• Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection.

  2015cited by this paper
• Positive hepatitis B virus core antibody in HIV infection—false positive or evidence of previous infection?

  2015cited by this paper
• [Prevention of mother to child transmission of hepatitis B].

  2015cited by this paper
• A case of false-positive test results in a pregnant woman of unknown HIV status at delivery.

  2014cited by this paper
• Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B

  2014cited by this paper
• Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance

  2014cited by this paper
• The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.

  2013cited by this paper
• [Value of FIB-4 for the diagnosis of liver fibrosis in chronic hepatitis B].

  2010cited by this paper
• Validation of FIB‐4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus‐infected patients

  2010cited by this paper
• From Abbott ARCHITECT anti-HBc to Anti-HBc II--improved performance in detecting antibodies to hepatitis B core antigen.

  2010cited by this paper
• Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors

  2010cited by this paper
• Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

  2009cited by this paper
• HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

  2005cited by this paper
• The laboratory diagnosis of hepatitis B virus.

  2005cited by this paper
• Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

  2004cited by this paper
• Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays.

  2002cited by this paper
• Interference in Immunoassay

  1999cited by this paper

• No citing papers are available for this paper.